Significant Shareholders

The following shareholders amount to 3% or more of the ordinary share capital of the company.

Shares in issue: 172,754,816 10p Ords

Significant Shareholders (>3%) Date Amount Holding %
Jupiter Asset Management Limited 17/09/2019 27,783,847 16.08%
FIL Limited 04/10/2019 14,051,552 8.13%
Dermot Keane 17/09/2019 12,777,088 7.40%
Conifer Management LLC 17/09/2019 12,032,522 6.97%
Legal & General 17/09/2019 10,369,092 6.00%
Andrew Newland 17/09/2019 7,054,686 4.08%

 

The shareholder positions shown above are accurate according to the formal independent Section 793 analysis undertaken on behalf of the Company by Argus Vickers as at 17 September 2019 modified for any known changes in shareholdings including notified TR1 forms and known issues of shares as at the date stated for each shareholder.

These shareholdings may differ from those shown on external electronic platforms, which are based solely on shareholder TR1 disclosures, because (i) fund managers may hold shares in multiple separate funds where part holdings are considered below disclosure requirement levels (ii) fund managers may not hold all of the voting rights of the shares (iii) some fund managers have exemption status under EU rules not to disclose TR1 holdings under 5% (rather than 3%) and (iv) external electronic platforms may not be up-to-date with new shareholder positions.

Video interview on Parsortix FDA submission View Here